Investment Rating - The report maintains an "Outperform" rating for Geely Automobile Holdings with a target price of HK$28.85 [2][4][15]. Core Insights - Geely's vehicle sales reached 1.409 million units in the first half of 2025, with expectations for significant growth in the second half due to a faster rollout of new models, likely exceeding the revised target of 3 million units for the year [4][15]. - The merger with Zeekr is expected to enhance Geely's core EV assets and strengthen its group platform strategy, aligning with the "One Geely" vision [5][16][17]. - The report forecasts vehicle deliveries of 3.11 million, 3.56 million, and 4.00 million units for 2025, 2026, and 2027, respectively, with NEV penetration rates of 56%, 57%, and 65% [4][15]. Financial Projections - Revenue is projected to grow from RMB 240.19 billion in 2024 to RMB 322.07 billion in 2025, with a year-on-year growth rate of 34% [9][10]. - Net profit is expected to remain stable at RMB 16.61 billion in 2025, with projected EPS of RMB 1.65, RMB 1.91, and RMB 2.07 for 2025, 2026, and 2027, respectively [9][10][13]. - The gross profit margin is anticipated to improve gradually, reaching 16.5% in 2025 and 16.8% by 2027 [9][10]. Strategic Merger Details - The merger with Zeekr, finalized on July 15, 2025, involved Geely acquiring all outstanding shares of Zeekr for approximately US$2.4 billion, with shareholders given the option of cash or stock [5][16]. - This merger is seen as a strategic move to consolidate resources, enhance operational efficiency, and secure core assets under Geely's control [6][19]. Product Launch Pipeline - Geely plans a robust product launch schedule in the second half of 2025, including several new models across its brands, which is expected to support the sales target of 3 million units [7][17].

Investment Rating - The report maintains a "Buy" rating for Harbin Electric, with a target price of HKD 10.50, based on a 10x PE valuation for 2025 [6][4]. Core Views - Harbin Electric is expected to achieve a significant increase in net profit for H1 2025, projected at CNY 1.02 billion, representing a 95% year-on-year growth from CNY 523 million in H1 2024. This growth is attributed to the fulfillment of new equipment orders and improved operational efficiency [1][2]. - The company is benefiting from a rebound in controllable power generation installations, with total revenue expected to reach CNY 23.05 billion in H1 2025, a 33.5% increase year-on-year. Revenue from coal, hydro, and nuclear power equipment is projected to grow significantly [2][3]. - The launch of the Yajiang hydropower project is anticipated to generate approximately CNY 36 billion in new orders for hydropower equipment, which will help sustain revenue growth and offset potential declines in coal power orders [3][4]. Summary by Sections Financial Performance - Harbin Electric's total revenue for 2024 is projected at CNY 38.72 billion, with a year-on-year growth of 32.38%. The net profit for 2024 is expected to be CNY 1.69 billion, reflecting a 193.27% increase [10][14]. - The company forecasts net profits of CNY 2.14 billion, CNY 2.65 billion, and CNY 3.11 billion for 2025, 2026, and 2027, respectively, with corresponding EPS of CNY 0.96, CNY 1.18, and CNY 1.39 [4][14]. Order and Revenue Projections - The report indicates that coal power equipment orders are expected to remain high at around CNY 18 billion in 2025, with hydropower and nuclear power equipment orders projected to grow by 14.5% and 13.5%, respectively [2][3]. - The total revenue from the power equipment production segment is expected to reach CNY 33.16 billion in 2025, with a year-on-year growth of 22.9% [12][13]. Market Outlook - The overall electricity consumption in China is projected to maintain a compound annual growth rate of 6% from 2025 to 2030, driven by new production capacities and increasing residential electricity demand [2][3]. - The report emphasizes the importance of the Yajiang project in providing a stable revenue stream that will align with the peak revenue from coal power equipment, thus ensuring continuous growth in traditional power equipment revenue [3][4].

Investment Rating - The investment rating for Tencent Holdings is "Buy" and is maintained [13] Core Insights - The report highlights that 2025 is widely regarded as the "Year of AI Agents," with AI Agents becoming a focal point of technology, as global tech giants accelerate their layouts in this area. Tencent is positioning itself to seize the high ground in the industry by deeply embedding AI Agents into its ecosystem, aiming to unlock incremental value in core businesses such as advertising, gaming, and enterprise services [4][7][8] Summary by Sections AI Agent Evolution - AI is transitioning from "information processing" to "action execution," with AI Agents capable of understanding user needs and autonomously planning and executing tasks. This evolution is expected to redefine enterprise operational paradigms and become a core competitive indicator for businesses [7][22][24] Value Chain Reconstruction - AI Agents are anticipated to drive changes in cost structures and reconstruct value distribution chains. They can act as "digital employees," enhancing cost competitiveness and potentially leading to new payment models, such as transitioning from traditional SaaS to "AI Agent as a Service" [8][42] Tencent's AI Agent Strategy - Tencent has established a comprehensive layout for AI Agents through a "model-tool-scenario" closed loop. The company employs a dual-engine strategy of "self-developed models + DeepSeek open-source" to build a multi-modal capability matrix. Tencent's AI core strategy is embodied in its product "Yuanbao," which integrates deeply with the WeChat ecosystem and supports multiple models [9][10][56] Future Outlook for AI Agents - Tencent's Yuanbao is positioned as the intelligent hub of its ecosystem, with significant user growth and engagement since its integration with DeepSeek. The product's competitive edge lies in its flexible model invocation and deep integration with WeChat [10][11] WeChat as an Ecosystem Connector - WeChat is identified as a super entry point for Tencent's AI Agent ecosystem, leveraging its vast user base and diverse data coverage to enhance advertising, subscription, and transaction revenue streams [11][12] Commercialization Potential - The report notes that AI Agents have substantial commercialization potential, with ongoing innovations in payment models and the ability to monetize structured data generated during service interactions. The shift towards usage-based billing models is highlighted as a significant trend [39][42][45]

Investment Rating - The report maintains a "Buy" rating for the company [1] Core Views - The main brand shows steady growth, while the performance of Saucony is promising, with a significant increase in retail sales [5][6] - In Q2 2025, the main brand's retail sales grew at a low single-digit percentage year-on-year, with retail discounts deepening slightly [5] - Saucony's retail sales increased by over 20% year-on-year in Q2 2025, and over 30% year-on-year for the first half of 2025 [5] Financial Performance Summary - The company expects to achieve revenues of RMB 144.1 billion, 155.2 billion, and 167.3 billion for 2025, 2026, and 2027 respectively, with corresponding net profits of RMB 13.7 billion, 15.3 billion, and 16.7 billion [5][7] - The projected P/E ratios for 2025, 2026, and 2027 are 10, 9, and 8 times respectively [5][7] - The report indicates a slight increase in channel inventory turnover days to 4-4.5 months as of H1 2025 [5] Market Data - As of July 18, 2025, the current stock price is HKD 5.47, with a market capitalization of approximately HKD 15,220.24 million [2][8] - The stock has shown a 28% increase over the past 12 months, compared to a 39.6% increase in the Hang Seng Index [2]

Investment Rating - The investment rating for Anta Sports (2020.HK) is "Buy" and is maintained [8]. Core Views - Anta's retail performance in Q2 2025 showed low single-digit growth for the Anta brand, while FILA brand experienced mid-single-digit growth, and other brands grew by 50%-55% year-on-year [2][6]. - The company is facing short-term operational pressure due to intensified competition and discounting, but the long-term outlook remains stable with expected healthy growth in revenue and net profit for H1 2025 [8]. - The forecast for net profit from 2025 to 2027 is projected at 134 billion, 150 billion, and 166 billion respectively, with year-on-year growth rates of 13%, 11%, and 11% [8]. Summary by Sections Retail Performance - Anta's retail performance in Q2 2025 was slightly below expectations, primarily due to adjustments in offline franchise stores and pressure from the 618 sales event [8]. - FILA's performance met expectations, with stable discounts in offline channels and a slight increase in e-commerce discounts [8]. Financial Projections - Total revenue projections for Anta are 70,826 million in 2024, 77,975 million in 2025, 85,282 million in 2026, and 92,167 million in 2027, reflecting growth rates of 13.58%, 10.09%, 9.37%, and 8.07% respectively [10]. - The projected net profit for 2025 is 13,420 million, showing a decrease of 13.95% compared to 2024, followed by increases of 11.47% and 10.93% in the subsequent years [10].

Investment Rating - The investment rating for the company is "Buy" (maintained) [1][6][9] Core Insights - The main brand of the company is experiencing short-term operational pressure, but there are expectations for improvement in the second half of 2025. In Q2 2025, the main brand recorded low single-digit year-on-year growth, while the FILA brand achieved mid-single-digit growth. Other brands saw a significant year-on-year growth of 50%-55% [5][6] - The acquisition of the outdoor brand Jack Wolfskin has been completed, which is expected to enhance the company's international expansion efforts. The acquisition was finalized on May 31, 2025, for a cash consideration of $290 million, and it is anticipated to improve product structure and retail efficiency through supply chain optimization [6][8] - The company is projected to achieve revenues of RMB 78.67 billion, RMB 87.65 billion, and RMB 96.79 billion for 2025, 2026, and 2027 respectively, with year-on-year growth rates of 11%, 11%, and 10%. The net profit attributable to the parent company is expected to be RMB 13.48 billion, RMB 15.51 billion, and RMB 17.25 billion for the same years, with a projected PE ratio of 18, 15, and 14 times [6][8][9] Summary by Sections Recent Performance - In Q2 2025, the main brand's revenue showed low single-digit growth year-on-year, while FILA's revenue grew in the mid-single digits. Other brands experienced a robust growth of 50%-55% year-on-year [5][6] Acquisition Impact - The acquisition of Jack Wolfskin is expected to facilitate the company's international market expansion and enhance its product offerings through advanced technology and sustainable innovations [6][8] Financial Projections - Revenue projections for 2025, 2026, and 2027 are RMB 78.67 billion, RMB 87.65 billion, and RMB 96.79 billion respectively, with corresponding net profits of RMB 13.48 billion, RMB 15.51 billion, and RMB 17.25 billion. The PE ratios are projected at 18, 15, and 14 times [6][8][9]

Investment Rating - The report maintains a "Strong Buy" rating for the company, with a target price of HKD 321.9 [2][8]. Core Insights - The company's H1 2025 performance exceeded expectations, with revenue growth projected to be at least 200%, corresponding to revenue of at least HKD 13.67 billion. The group's profit growth is expected to be at least 350%, corresponding to a profit of at least HKD 4.34 billion, with a profit margin of approximately 31.7%, an increase of 10.6 percentage points year-on-year [2][8]. - The report highlights the ongoing enhancement of brand momentum and the successful expansion of the IP ecosystem, with new product launches receiving positive market feedback [2][8]. - The company is expected to continue its impressive performance in the domestic market while expanding its presence in overseas markets, supported by the influence of celebrity endorsements [2][8]. Financial Summary - Projected total revenue for 2024 is HKD 13.04 billion, with a year-on-year growth rate of 105.5%. By 2025, revenue is expected to reach HKD 30.05 billion, reflecting a growth rate of 130.5% [4][9]. - The projected net profit for 2024 is HKD 3.13 billion, with a year-on-year growth rate of 188.8%. By 2025, net profit is expected to increase to HKD 9.38 billion, with a growth rate of 200.1% [4][9]. - The report anticipates a steady increase in earnings per share (EPS), projected at HKD 2.33 for 2024, rising to HKD 6.98 in 2025 [4][9].

Investment Rating - The report maintains a "Buy" rating for the company [5] Core Insights - The company has won a significant procurement order for humanoid robots, valued at 90.51 million yuan, marking it as the largest order globally for humanoid robots [2] - The company is at the forefront of humanoid robot commercialization, with multiple products gradually being deployed [2] - The company has developed a unique group intelligence technology that facilitates the large-scale deployment of humanoid robots in industrial settings [3] - The Walker S2 robot features a pioneering hot-swappable autonomous battery replacement system, enabling continuous operation [4] Financial Projections - Revenue forecasts for the company are set at 20.16 billion yuan for 2025, 28.23 billion yuan for 2026, and 37.05 billion yuan for 2027, with corresponding price-to-sales ratios of 17, 12, and 9 times [5] - The company is projected to have a net profit of -1.03 billion yuan in 2025, improving to -0.74 billion yuan in 2026 and -0.23 billion yuan in 2027 [5] - The earnings per share (EPS) is expected to improve from -2.33 yuan in 2025 to -0.52 yuan in 2027 [5]

Investment Rating - The report initiates coverage with a "Strong Buy" investment rating for the company [1]. Core Insights - The company, Zhaoyan New Drug, is positioned as a leader in the domestic CRO industry, particularly in safety evaluation, with comprehensive GLP qualifications and strategic resources in experimental monkeys. The company is expected to benefit from rising prices of experimental monkeys due to supply constraints and strong demand [1][8]. - The report highlights the mismatch between supply and demand for experimental monkeys, which is driving a price recovery trend. The aging population of breeding monkeys and the long breeding cycle are significant factors affecting supply [2][8]. - The company is expanding its offshore outsourcing business, which is anticipated to create a new growth engine, alongside the recovery of domestic demand [8][42]. Financial Data and Valuation - The projected financial performance shows total revenue decreasing from 2,377 million in 2023 to 1,977 million in 2025E, with a subsequent recovery to 2,468 million by 2027E. The net profit is expected to rebound significantly from 74 million in 2024 to 352 million in 2025E [3][4]. - The company’s PE ratio is projected to be 39.8 in 2025E, decreasing to 24.4 by 2027E, indicating an improving valuation as earnings recover [3][4]. Supply and Demand Dynamics - The supply of experimental monkeys is constrained due to an aging population and a long breeding cycle, with over 80% of breeding females being over 8 years old as of 2023. This has led to a significant decline in breeding rates [8][19]. - Demand for experimental monkeys is expected to improve, particularly for biopharmaceutical research, as over 70% of large molecule drugs require monkeys for preclinical trials [26][28]. Strategic Initiatives - The company has made strategic acquisitions, including monkey breeding facilities, to enhance its supply chain and reduce costs, thereby increasing profitability [8][60]. - The offshore outsourcing strategy is showing positive results, with higher gross margins from overseas orders, which is expected to enhance overall profitability [52][54]. Management and Governance - The management team has extensive experience in drug safety evaluation and a solid governance structure, with key figures holding significant shares in the company [36][40].

Investment Rating - The investment rating for the company is "Buy" with a target price of HKD 53.59, compared to a closing price of HKD 43.00 as of July 18, 2025 [1]. Core Views - The report highlights a recovery in the packaging water market share for the company, with a strong growth trend expected to continue in 2025. The company is reallocating its marketing expenses from green bottle purified water to red bottle natural water, which has shown a significant recovery in market share since the low point in 2024 [5][6]. - The company is also focusing on expanding its product lines, including NFC juice, carbonated coffee, and iced tea, which are anticipated to contribute to revenue growth [5][6]. - The report anticipates that the industry cost advantages will persist in 2025, positively impacting the company's gross margin, while the expense ratio is expected to decrease year-on-year [5][9]. Summary by Sections Financial Projections - Revenue is projected to grow from RMB 42,896 million in 2024 to RMB 59,508 million by 2027, reflecting a compound annual growth rate (CAGR) of approximately 9.19% [4]. - Net profit attributable to the parent company is expected to increase from RMB 12,123 million in 2024 to RMB 17,902 million in 2027, with a CAGR of 9.49% [4]. - The earnings per share (EPS) is forecasted to rise from RMB 1.08 in 2024 to RMB 1.59 in 2027 [4]. Market Position and Competitive Landscape - The report notes that the competitive landscape in the packaging water industry has eased since 2025, allowing the company to regain market share [5]. - The company is recognized as a relatively rare platform-type enterprise within the soft drink sector, with a strong focus on consumer education and product innovation [6]. Valuation Metrics - The report adjusts the earnings forecast for 2025-2027, with EPS estimates revised to RMB 1.29, RMB 1.45, and RMB 1.59 respectively, reflecting an increase of 4% from previous estimates [7]. - The target price of HKD 53.59 corresponds to a price-to-earnings (PE) ratio of 38x for 2025, indicating a premium valuation due to the company's strong market position and competitive advantages [7].